A role for IgG immune complexes during infection with the intracellular pathogen Leishmania
Open Access
- 7 March 2005
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 201 (5), 747-754
- https://doi.org/10.1084/jem.20041470
Abstract
We examined the role of immunoglobulin (Ig)G antibodies in mediating host defense to the intracellular parasite, Leishmania. We show that IgG not only fails to provide protection against this intracellular pathogen, but it actually contributes to disease progression. The JH strain of BALB/c mice, which lack IgG because they have a targeted deletion in the Ig heavy chain (J) locus, were more resistant to infection with Leishmania major than were normal BALB/c mice. However, the passive administration of anti-Leishmania IgG caused JH mice to develop large lesions containing high numbers of parasites. Antibody administration correlated with an increase in interleukin (IL) 10 production in lesions, and blocking the murine IL-10 receptor prevented antibody-mediated disease exacerbation. In human patients with active visceral leishmaniasis, high IgG levels are predictive of disease. Patients with ongoing disease had high IgG antibody titers and no delayed-type hypersensitivity (DTH) responses to Leishmania antigens. This pattern was reversed upon disease resolution after treatment, resulting in a decrease in total IgG, which was accompanied by a progressive increase in DTH responsiveness. We conclude that IgG can cause a novel form of immune enhancement due to its ability to induce IL-10 production from macrophages.Keywords
This publication has 40 references indexed in Scilit:
- Use of Genetic Profiling in Leprosy to Discriminate Clinical Forms of the DiseaseScience, 2003
- CD4+CD25+ regulatory T cells control Leishmania major persistence and immunityNature, 2002
- A simple and reproducible method to obtain large numbers of axenic amastigotes of different Leishmania speciesZeitschrift für Parasitenkunde, 2002
- Interleukin-10 (IL-10) in Experimental Visceral Leishmaniasis and IL-10 Receptor Blockade as ImmunotherapyInfection and Immunity, 2002
- Distinct Immunity in Patients with Visceral Leishmaniasis from that in Subclinically Infected and Drug‐Cured People: Implications for the Mechanism Underlying Drug CureThe Journal of Infectious Diseases, 2001
- Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced MacrophagesScience, 1993
- Epidemiology of Visceral Leishmaniasis in Northeast BrazilThe Journal of Infectious Diseases, 1992
- Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector functionImmunology Today, 1991
- Immunological regulation of experimental cutaneous leishmaniasis. 1. Immunogenetic aspects of susceptibility to Leishmania tvopica in miceParasite Immunology, 1980
- Antibody-enhanced dengue virus infection in primate leukocytesNature, 1977